Japan Breast Cancer Research Group

The Japan Breast Cancer Research Group (JBCRG) is a leading non-profit academic research organization (ARO) based in Tokyo, Japan, dedicated to the advancement of breast cancer therapeutics through multicenter clinical trials. Established in 2002, the group facilitates investigator-initiated research by collaborating with a vast network of medical institutions and pharmaceutical partners to evaluate novel drugs and treatment strategies. JBCRG's portfolio includes a wide range of Phase 1 through Phase 3 trials focusing on molecularly targeted therapies, immunotherapies, and optimized chemotherapy regimens. The organization plays a pivotal role in establishing new standards of care for breast cancer patients in Japan and contributes significantly to global clinical evidence. Their research spans various subtypes, including HER2-positive, triple-negative, and hormone receptor-positive breast cancers.